Vasohibin-1 Antibodies

Santa Cruz Biotechnology offers a broad range of Vasohibin-1 monoclonal antibodies for research in understanding this important protein's role. Vasohibin-1 Antibodies are validated for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). Vasohibin-1 is a key regulator of angiogenesis, playing a critical role in the inhibition of endothelial cell proliferation and migration. Its function is vital in maintaining vascular homeostasis and has implications in various pathological conditions, including cancer and cardiovascular diseases. Understanding Vasohibin-1 mechanisms can provide insights into therapeutic strategies targeting angiogenesis. Researchers can investigate Vasohibin-1's role in both normal physiological processes and disease states. The relationship between Vasohibin-1 and tumor progression has become an area of significant interest in cancer research. Multiple studies have demonstrated Vasohibin-1's potential as a therapeutic target in various cancers. Santa Cruz Biotechnology monoclonal antibodies enable researchers worldwide to advance their understanding of Vasohibin-1's role in human health and disease development.